NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
ARCA biopharma Inc (NASDAQ: ABIO)
ABIO Technical Analysis
1.5
As on 9th Jun 2023 ABIO SHARE Price closed @ 2.06 and we RECOMMEND Sell for LONG-TERM with Stoploss of 2.23 & Buy for SHORT-TERM with Stoploss of 2.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ABIOSHARE Price
Open | 2.07 | Change | Price | % |
High | 2.10 | 1 Day | -0.01 | -0.48 |
Low | 2.04 | 1 Week | -0.05 | -2.37 |
Close | 2.06 | 1 Month | 0.07 | 3.52 |
Volume | 18113 | 1 Year | -0.27 | -11.59 |
52 Week High 2.55 | 52 Week Low 1.77 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
ABIO Daily Charts |
ABIO Intraday Charts |
Whats New @ Bazaartrend |
ABIO Free Analysis |
|
ABIO Important Levels Intraday
RESISTANCE | 2.18 |
RESISTANCE | 2.14 |
RESISTANCE | 2.12 |
RESISTANCE | 2.09 |
SUPPORT | 2.03 |
SUPPORT | 2.00 |
SUPPORT | 1.98 |
SUPPORT | 1.94 |
ABIO Forecast March 2024
4th UP Forecast | 2.89 |
3rd UP Forecast | 2.62 |
2nd UP Forecast | 2.46 |
1st UP Forecast | 2.29 |
1st DOWN Forecast | 1.83 |
2nd DOWN Forecast | 1.66 |
3rd DOWN Forecast | 1.5 |
4th DOWN Forecast | 1.23 |
ABIO Weekly Forecast
4th UP Forecast | 2.64 |
3rd UP Forecast | 2.45 |
2nd UP Forecast | 2.34 |
1st UP Forecast | 2.22 |
1st DOWN Forecast | 1.90 |
2nd DOWN Forecast | 1.78 |
3rd DOWN Forecast | 1.67 |
4th DOWN Forecast | 1.48 |
ABIO Forecast2024
4th UP Forecast | 3.97 |
3rd UP Forecast | 3.36 |
2nd UP Forecast | 2.98 |
1st UP Forecast | 2.6 |
1st DOWN Forecast | 1.52 |
2nd DOWN Forecast | 1.14 |
3rd DOWN Forecast | 0.76 |
4th DOWN Forecast | 0.15 |
ARCA biopharma Inc ( NASDAQ USA Symbol : ABIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ABIO Other Details
Segment | EQ | |
Market Capital | 37754460.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
ABIO Address
ABIO Latest News
ABIO Business Profile
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase 2 clinical trial for the treatment of diseases caused by ribonucleic acid viruses initially focusing on COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase 2 trial for the treatment of atrial fibrillation in patients with chronic heart failure (HF). The company also engages in the development of AB171, a thiol-containing derivative isosorbide mononitrate for the treatment of HF and peripheral arterial disease. ARCA biopharma, Inc. is headquartered in Westminster, Colorado. Address: 10170 Church Ranch Way, Westminster, CO, United States, 80021
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service